APA

Pluschnig U., Schoppmann S. F., Preusser M., Datler P., Asari R., Ba-Ssalamah A., Schwameis K., Birner P., Zacherl J. & Hejna M. (20130516). Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma. : Anticancer research.

Chicago

Pluschnig Ursula, Schoppmann Sebastian F, Preusser Matthias, Datler Philip, Asari Reza, Ba-Ssalamah Ahmed, Schwameis Katrin, Birner Peter, Zacherl Johannes and Hejna Michael. 20130516. Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma. : Anticancer research.

Harvard

Pluschnig U., Schoppmann S. F., Preusser M., Datler P., Asari R., Ba-Ssalamah A., Schwameis K., Birner P., Zacherl J. and Hejna M. (20130516). Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma. : Anticancer research.

MLA

Pluschnig Ursula, Schoppmann Sebastian F, Preusser Matthias, Datler Philip, Asari Reza, Ba-Ssalamah Ahmed, Schwameis Katrin, Birner Peter, Zacherl Johannes and Hejna Michael. Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma. : Anticancer research. 20130516.